HDII (Hypertension Diagnostics) 3-1 Month Momentum %: N/A% (As of Jul. 12, 2026)


What is Hypertension Diagnostics 3-1 Month Momentum %?

Hypertension Diagnostics HDII -99.00% 3-1 Month Momentum % is N/A% as of Jul. 12, 2026.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-12), Hypertension Diagnostics's 3-1 Month Momentum % is N/A%.

The industry rank for Hypertension Diagnostics's 3-1 Month Momentum % or its related term are showing as below:

HDII's 3-1 Month Momentum % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 0.6
* Ranked among companies with meaningful 3-1 Month Momentum % only.

Hypertension Diagnostics  (OTCPK:HDII) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Hypertension Diagnostics 3-1 Month Momentum % Related Terms

HDII vs ESTRF, OCLN, PTOI: 3-1 Month Momentum % Comparison

For the Shell Companies subindustry, Hypertension Diagnostics's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics 3-1 Month Momentum % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's 3-1 Month Momentum % falls into.


Hypertension Diagnostics  (OTCPK:HDII) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of N/A% mean?
Hypertension Diagnostics (HDII) has a 3-1 Month Momentum % of N/A% as of Jul. 12, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' 3-1 Month Momentum % too high?
Hypertension Diagnostics' current 3-1 Month Momentum % is N/A%.
How does Hypertension Diagnostics' 3-1 Month Momentum % compare to ESTRF and OCLN?
Hypertension Diagnostics' 3-1 Month Momentum % of N/A% can be compared against companies in the Diversified Financial Services industry. The industry median 3-1 Month Momentum % is 0.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Diversified Financial Services company?
The median 3-1 Month Momentum % among Diversified Financial Services companies is 0.60, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Hypertension Diagnostics and its competitors. For the Diversified Financial Services industry, the median 3-1 Month Momentum % is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypertension Diagnostics's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current 3-1 Month Momentum % of N/A%. The current 3-1 Month Momentum % is N/A%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current 3-1 Month Momentum % is N/A% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.